Medicinal Genomics

Medicinal Genomics

Medicinal Genomics is a life sciences company that distributes genetics-based platforms for quality and safety testing of legal cannabis.
Testing & Compliance

About Medicinal Genomics

In addition to our testing platform, we provide services enabling legal cannabis cultivators and distributors to genetically identify cannabis strains so that the medical community can track those cannabis products that provide the maximum patient benefit and product reliability. The MGC Strain ID solution also enables growers to generate the foundational information for documenting and publishing their Intellectual Property for strains they develop.

MGC was founded by Kevin McKernan, a world renowned leader in DNA sequencing technology, pioneering researcher and thought leader in cannabis genetics. MGC was the first company to sequence the cannabis genome and has subsequently sequenced hundreds of different cannabis strain genomes. This groundbreaking work has allowed MGC to provide the science for cannabis identification and safety in ways that profoundly enhance the scientific validation of the healing powers of this natural medicine.

Team

Charles Farkas
Chairman of the Board
BRENDAN MCKERNAN
CEO
Phillip Chapman
Board Member
Kevin McKernan
CSO and Founder
Mark DeBlois
Board Member
Richard Upton
Board Member
TRACY MARSHBANKS
BOARD OBSERVER
TIM OLCOTT
VICE PRESIDENT, OPERATIONS
DOUG KENNEDY
CANNMED EVENTS DIRECTOR
YVONNE HELBERT
SENIOR SCIENTIST
HEATHER EBLING
SENIOR APPLICATIONS & SUPPORT MANAGER Ben Amiraul...
BEN AMIRAULT
MARKETING MANAGER
KATE LANDRY
CONTROLLER
ZAC EATON
SENIOR SALES REPRESENTATIVE
KEVIN SCHNITZLER
SENIOR SALES REPRESENTATIVE
KYLE BOYAR
FIELD APPLICATIONS SCIENTIST
BLAIR BEACH
CUSTOMER SUPPORT SPECIALIST
DENISE MARSTON
HUMAN RESOURCES/OFFICE MANAGER
ADAM COX
QUALITY ASSURANCE/OPERATIONS SPECIALIST
MEGAN HOWARD
ACCOUNTING ASSISTANT
LIAM KANE
R&D INTERN/CO-OP
ERIC SUH
TIM HARKINS
FRANK PRISCARO

Participation in events